JP2021505542A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505542A5
JP2021505542A5 JP2020529321A JP2020529321A JP2021505542A5 JP 2021505542 A5 JP2021505542 A5 JP 2021505542A5 JP 2020529321 A JP2020529321 A JP 2020529321A JP 2020529321 A JP2020529321 A JP 2020529321A JP 2021505542 A5 JP2021505542 A5 JP 2021505542A5
Authority
JP
Japan
Prior art keywords
formula
compound
salt
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020529321A
Other languages
English (en)
Japanese (ja)
Other versions
JP7402159B2 (ja
JP2021505542A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/063070 external-priority patent/WO2019108797A1/en
Publication of JP2021505542A publication Critical patent/JP2021505542A/ja
Publication of JP2021505542A5 publication Critical patent/JP2021505542A5/ja
Priority to JP2023152281A priority Critical patent/JP7787859B2/ja
Application granted granted Critical
Publication of JP7402159B2 publication Critical patent/JP7402159B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020529321A 2017-11-30 2018-11-29 薬物リンカー化合物の調製のためのプロセス Active JP7402159B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023152281A JP7787859B2 (ja) 2017-11-30 2023-09-20 薬物リンカー化合物の調製のためのプロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762593104P 2017-11-30 2017-11-30
US62/593,104 2017-11-30
PCT/US2018/063070 WO2019108797A1 (en) 2017-11-30 2018-11-29 Process for the preparation of drug linker compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023152281A Division JP7787859B2 (ja) 2017-11-30 2023-09-20 薬物リンカー化合物の調製のためのプロセス

Publications (3)

Publication Number Publication Date
JP2021505542A JP2021505542A (ja) 2021-02-18
JP2021505542A5 true JP2021505542A5 (https=) 2022-01-06
JP7402159B2 JP7402159B2 (ja) 2023-12-20

Family

ID=66665808

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020529321A Active JP7402159B2 (ja) 2017-11-30 2018-11-29 薬物リンカー化合物の調製のためのプロセス
JP2023152281A Active JP7787859B2 (ja) 2017-11-30 2023-09-20 薬物リンカー化合物の調製のためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023152281A Active JP7787859B2 (ja) 2017-11-30 2023-09-20 薬物リンカー化合物の調製のためのプロセス

Country Status (15)

Country Link
US (2) US11612666B2 (https=)
EP (1) EP3717016A4 (https=)
JP (2) JP7402159B2 (https=)
KR (2) KR20250024092A (https=)
CN (2) CN111417408B (https=)
AU (1) AU2018375412B2 (https=)
BR (1) BR112020010503A2 (https=)
CA (1) CA3082165A1 (https=)
EA (1) EA202091340A1 (https=)
IL (1) IL274757B2 (https=)
MA (1) MA51870A (https=)
MX (2) MX2020005565A (https=)
SG (1) SG11202004698RA (https=)
WO (1) WO2019108797A1 (https=)
ZA (1) ZA202003037B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7167163B2 (ja) * 2019-05-20 2022-11-08 煙台邁百瑞国際生物医薬股▲ふん▼有限公司 抗体-薬物コンジュゲートの中間体のワンポット合成法による製造プロセス
CN110945009B (zh) * 2019-10-23 2023-10-31 烟台迈百瑞国际生物医药股份有限公司 一种寡肽连接子中间体及其制备方法
AU2022238571A1 (en) 2021-03-18 2023-09-14 Seagen Inc. Selective drug release from internalized conjugates of biologically active compounds
CN115873066A (zh) * 2022-07-27 2023-03-31 吉林省博大伟业制药有限公司 一种抗体偶联药物连接子的合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
US7498298B2 (en) * 2003-11-06 2009-03-03 Seattle Genetics, Inc. Monomethylvaline compounds capable of conjugation to ligands
WO2007031734A1 (en) * 2005-09-14 2007-03-22 Ucb Pharma S.A. Comb polymers
MX2009002855A (es) * 2006-09-15 2009-03-30 Enzon Pharmaceuticals Inc Profarmacos polimericos dirigidos que contienen enlazadores multifuncionales.
ES2569483T3 (es) * 2007-06-21 2016-05-11 Amgen Inc. Métodos para sintetizar cinacalcet y sales del mismo
KR102356286B1 (ko) * 2011-05-27 2022-02-08 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
US9981046B2 (en) * 2012-05-15 2018-05-29 Concortis Biosystems, Corp., a wholly owned Subsidiary of Sorrento Therapeutics, Inc. Drug-conjugates, conjugation methods, and uses thereof
SI2941432T1 (en) * 2012-12-07 2018-07-31 Vertex Pharmaceuticals Incorporated 2-AMINO-6-FLUORO-N- (5-FLUORO-4- (4- (4- (OXETHAN-3-YL) PIPERAZIN-1-CARBONYL) PIPERIDIN-1-YLIPRIDIN-3-YL) 1,5 ALFA) PYRIMIDINE-3-CARBOXAMIDE AS ATR KINAZE INHIBITOR
GB201309807D0 (en) * 2013-05-31 2013-07-17 Pharma Mar Sau Antibody drug conjugates
GB201416960D0 (en) * 2014-09-25 2014-11-12 Antikor Biopharma Ltd Biological materials and uses thereof
US9533483B2 (en) 2014-09-26 2017-01-03 Kimberly-Clark Worldwide, Inc. Apparatus for and method of shaping and applying a segment to a moving web

Similar Documents

Publication Publication Date Title
JP2021505542A5 (https=)
JP4727994B2 (ja) ビフェニル誘導体および殺真菌剤としてのそれらの使用
IL274757B1 (en) Process for the preparation of drug linker compounds
US20040171838A1 (en) Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom
MY140528A (en) Spiroketal derivatives and their use as therapeutic agents for diabetes
WO2007143526A2 (en) Substituted tetrahydroimidazonaphthyridines and methods
NO20051411L (no) Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk bruk derav samt intermediater til fremstilling derav
MX2007010879A (es) Procedimiento para preparar compuestos macrociclicos.
JP2007507542A5 (https=)
AU2018371771A1 (en) Solid state form of Valbenazine
SG191841A1 (en) Methods of making hiv attachment inhibitor prodrug compound and intermediates
CA2539975A1 (en) 9,10-.alpha.,.alpha.-oh-taxane analogs and methods for production thereof
ATE482933T1 (de) Sulfopyrrolderivate
CN106083807B (zh) 4-氨基-5-联苯-4-基-2-羟甲基-2-甲基-戊酸化合物及其制备方法
JP2005520863A (ja) 殺菌剤として有用なケイ素化フェニルアミド誘導体
Nedolya et al. A one-pot synthesis and mild cleavage of 2-[2-or 5-(alkylsulfanyl) pyrrol-1-yl] ethyl vinyl ethers by t-BuOK/DMSO: a novel and facile approach to N-vinylpyrroles
NZ592766A (en) 1,4-dihydropyridine-fused heterocycles, process for preparing the same, use and compositions containing them
AU2018397684B2 (en) Process for the preparation of an amino-pyrimidine and intermediates thereof
CN101633669A (zh) 选择性硅醚化保护雷帕霉素31位或42位羟基的新方法
CN101155809A (zh) 他达那非中间体的制备
CN101044119A (zh) 制备吡唑类化合物的方法
ES2232309B1 (es) Procedimiento simplificado para la obtencion de gatifloxacino.
US9657037B2 (en) Pyrrole compounds with silicon incorporation
WO2008155745A2 (en) New process for the manufacture of 1h-imidazo[4,5-c]-quinoline ring systems
AU2004309056A1 (en) Process for the preparation of triazolopyrimidines